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 SUMMARY 
 
IgG4-related disease (IgG4-RD) is a newly-recognised, multi-organ, inflammatory 
disease and its full clinical spectrum remains undefined. We present a biopsy-proven 
case of IgG4-RD presenting with a parapharyngeal mass with intra-cranial extension 
and possible involvement of the brain parenchyma. We highlight the importance of 
considering the diagnosis in those presenting with tumefactive lesions, 
leptomeningitis or pachymeningitis and emphasise the value of securing a tissue 
diagnosis so that appropriate long-term treatment can be instigated and 
complications avoided. 
 
 
INTRODUCTION 
 
The complete clinical spectrum of IgG4-related disease remains to be determined 
following its relatively recent recognition as a distinct entity. It typically causes 
painless swelling and can affect either one organ in isolation or multiple organs[1 2]. 
Fever, malaise, sweats and weight loss occur less commonly. Here, we present the 
case of a gentleman with both intra- and extra-cranial manifestations of IgG4-related 
disease with spread of the disease via the skull base foramina. 
 
 
Case Report 
 
A 46-year-old right-handed construction worker presented with a 12-month history of 
fatigue, weight loss (25kg), headache, right-sided facial numbness and diplopia on 
gaze to the right. On examination, there was right-sided trigeminal sensory 
impairment (Va/b/c), partial right sixth nerve palsy and right-sided tongue wasting.  
 
Peripheral blood markers of inflammation were elevated. Screening for 
immunodeficiency and mycobacterial infection was negative. Chest x-ray and chest, 
abdomen and pelvis CT were normal.  
 
 MRI (Figure 1A-D) demonstrated an enhancing soft tissue mass involving the right 
posterior nasopharynx with intracranial spread through the right carotid canal, jugular 
foramen and foramen ovale. There was basal pachy- and leptomeningitis in the 
middle cranial fossa with high signal in the overlying temporal lobe. There was no 
significant lymphadenopathy. MRV confirmed patency of the major dural venous 
sinuses. Biopsy of the parapharyngeal space on two occasions was non-diagnostic. 
 
Three months later, the patient experienced worsening headache and developed 
bilateral haemorrhagic papilloedema. Treatment with intravenous 
methylprednisolone (1g) for 3 days followed by 60mg prednisolone orally led to 
symptomatic and radiological improvement but development of steroid-induced 
diabetes. Weaning of prednisolone to 15mg over the course of 9 months was 
associated with development of right-sided facial swelling consistent with 
dacryosialoadenopathy. There was re-emergence of diplopia with reduced left-sided 
visual acuity signs were consistent with left-sided optic neuropathy. Sensation was 
reduced in a Vb/c distribution on the right and right-sided tongue wasting was 
apparent. Weber’s localized to the right. There was clinical evidence to support the 
development of peripheral neuropathy but no other limb signs.  
 
MR imaging was repeated (Figure 1D) and, although there was resolution of the 
abnormality previously noted in the right temporal lobe and stable disease along the 
tentorium and in the cavernous sinus, progressive changes were noted in the 
pterygomaxillary fissure, the muscles of the masticator compartment and throughout 
temporalis on the right.  
 
A diffuse plasma cell-rich, chronic inflammatory cell infiltrate was noted on biopsy of 
anterior temporalis and posterior maxilla. There was prominent stromal 
fibrosis/hyalinization, fat necrosis with focal granulation tissue and numerous IgG 
and IgG4-positive plasma cells (Figure 1E-G). 
 
High dose corticosteroid treatment was re-instigated with resolution of signs within a 
fortnight. FDG-PET performed after re-introduction of corticosteroid therapy did not 
show any enhanced uptake. Azathioprine was commenced and the dose of 
 prednisolone has been successfully weaned to 10mg daily over 1 year without 
recurrence of clinical signs.  
 
 
DISCUSSION 
 
IgG4-related disease has only recently been appreciated as a distinct clinical entity 
although the pathological changes are now known to occur in several long-
recognised conditions such as Mikulicz syndrome[3], autoimmune pancreatitis[4] and 
Riedel’s thyroiditis[5]. Whilst the full spectrum of the clinical phenotype remains 
undetermined, characteristic histopathological findings have been described in 
almost every organ[1 6 7]. In the CNS, lepto- and pachymeningitis as well as 
hypophysitis, pseudotumours and cranial neuropathy are recognized manifestations 
but involvement of brain parenchyma is rare[8 9]. A single case report has previously 
documented intra-cranial extension of disease via the foramen ovale along the 
trigeminal nerve[10]. 
 
The finding of an elevated serum IgG4 concentration is supportive of IgG4-RD but is 
not a constant finding[2] and whether IgG4, a relatively weak activator of effector 
cells, is pathogenic is uncertain[11].  
 
In the head and neck, hypointense T2 lesions on MR are typical and enhancement 
with gadolinium may occur[12]. 11C-methionine (MET) positron emission 
tomography (PET) may be superior to 18F-ﬂuorodeoxy-glucose (FDG) PET for the 
detection of CNS disease.[13] Nonetheless, with the possible exception of 
autoimmune pancreatitis[14], the radiological features are not pathognomonic and 
cannot reliably differentiate IgG4-RD from other inflammatory, multi-organ diseases 
such as Wegener’s granulomatosis and Sjogren’s syndrome. 
 
The diagnosis of IgG4-RD therefore relies on histology - consensus diagnostic 
criteria are based on morphological appearances including presence of a dense 
lymphoplasmacytoid infiltrate, fibrosis (usually storiform) and obliterative 
phlebitis[15]. An eosinophilic infiltrate may occur but is not a prerequisite for the 
diagnosis. 
  
IgG4-RD typically responds to treatment with glucocorticoids but steroid-sparing 
agents such as azathioprine, methotrexate or mycophenolate mofetil may be 
required to reduce the risk of relapse with steroid withdrawal[6]. Successful 
treatment of CNS IgG4-RD with rituximab has also been reported[8]. 
 
We present a case of IgG4-RD with contiguity of intra- and extra-cranial disease via 
skull base foramina. Although there was radiological evidence of cerebral 
parenchymal involvement, this may be due to vasogenic oedema or direct brain 
involvement; biopsy of extra-cranial disease was preferentially undertaken in view of 
favourable risk profile. Nonetheless, this case adds to the reported clinical spectrum 
of IgG4-RD, definition of which will be important for prompt recognition of this 
relatively new clinical entity and subsequent initiation of appropriate treatment and 
avoidance of complications.   
 
 
KEY MESSAGES 
 
IgG4-related disease should be considered in the differential diagnosis of CNS 
pseudotumour, cranial neuropathy, hypophysitis and lepto- or pachymeningitis 
 
IgG4-related disease may present with a combination of intra- and extracranial 
manifestations 
 
Early recognition of IgG-related disease and establishment of appropriate long-term 
treatment may avoid unnecessary investigations and morbidity 
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 FIGURES AND LEGENDS 
 
 
Figure 1 MR imaging (1A, B) demonstrated an enhancing soft tissue mass involving 
the right posterior nasopharynx with infiltration laterally and posteriorly into the right 
prevertebral strap muscles and through the pharyngobasilar fascia to involve the 
medial and lateral pterygoids. The right carotid and internal carotid artery was 
ensheathed and abnormal tissue was seen in the right carotid canal and jugular 
foramen. The right cavernous sinus was involved via perineural spread through the 
foramen ovale. Basal pachy- and leptomeningitis were noted along the floor of the 
right middle cranial fossa with high signal in the overlying temporal lobe (1C). 
Progressive changes were noted in the pterygomaxillary fissure, the muscles of the 
masticator compartment and throughout the temporalis muscle on the right at the 
time of re-presentation (1D). 
 
Figure 1E-G A diffuse plasma cell-rich, chronic inflammatory cell infiltrate with 
prominent stromal fibrosis/hyalinization, fat necrosis and focal granulation tissue was 
evident on biopsy of anterior temporalis and posterior maxilla (1E). 
Immunocytochemistry demonstrated numerous IgG and IgG4 positive plasma cells 
(1F and 1G). 
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